Use of metabolic surgery for the treatment of type 2 diabetes

Canadian Journal of Diabetes

Volumn 35, Issue 2, 2011, Pages 99-108

  Anvari, Mehran ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Bariatric surgery; Body mass index; Obesity; Type 2 diabetes

Indexed keywords

BARIATRIC SURGERY; BODY MASS; COMORBIDITY; DIABETIC PATIENT; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; MORBID OBESITY; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RECURRENCE RISK; REVIEW; RISK BENEFIT ANALYSIS; STOMACH BYPASS; SURGICAL APPROACH; SURGICAL MORTALITY; SURGICAL RISK; TREATMENT OUTCOME; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION;

EID: 79958028357     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-2671(11)52006-4     Document Type: Review

References (43)

1. World Health Organization, Media Centre. Diabetes: Key Facts. http://www.who.int/mediacentre/factsheets/fs312/en. Accessed on March 25, 2011.
2. Diabetes Action Now: An Initiative of the World Health Organization and the International Diabetes Federation. http://www.who.int/diabetes/ actionnow/en/. Accessed on March 25, 2011.
3. World Health Organization. Facts about obesity and overweight. http://www.who.int/dietphysicalactivity/publications/facts/obesity/en. Accessed on March 14, 2011.
4. Dinca-Panaitescu S, Dinca-Panaitescu M, Bryant T, et al. Diabetes prevalence and income: Results of the Canadian Community Health Survey. Health Policy. 2010;99:116-123.
5. Lau DC. Diabetes and weight management. Prim Care Diabetes.2010;4(Suppl 1):S24-S30.
6. Narayan KM, Boyle JP, Thompson TJ, et al. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care. 2007;30:1562-1566.
7. Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001;161:1581-1586.
8. Stern L, Iqbal N, Seshadri P, et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one year follow-up of a randomized trial. Ann Intern Med. 2004;140:778-785.
9. Padwal R, Li SK, Lau DC. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev. 2004(3):CD004094.
10. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and metaanalysis. Am J Med.2009;122:248-256.
11. Sims EA. Experimental obesity, dietary-induced thermogenesis, and their clinical implications. Clin Endocrinol Metab. 1976;5:377-395.
12. Angel A, Winocur JT, Roncari DA. Morbid obesity. The problem and its consequences. In: Deitel M, ed. Surgery for the Morbidly Obese Patient. Philadelphia, PA: Lea & Febiger; 1989:20-25.
13. Marceau P. Contribution of bariatric surgery to the comprehension of morbid obesity. Obes Surg. 2005;15:3-10.
14. Miller DS, Mumford P, Stock MJ. Gluttony. 2. Thermogenesis in overeating man. Am J Clin Nutr. 1967;20:1223-1229.
15. Dulloo AG, Jacquet J. An adipose-specific control of thermogenesis in body weight regulation. Int J Obes Relat Metab Disord. 2001;25(suppl 5): S22-S29.
16. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure resulting from altered body weight. N Engl J Med. 1995;332:621-628.
17. M. Surgery for diabetes at lower BMI: some caution. Obes Surg.2008;18:1211-1214.
18. Patriti A, Facchiano E, Sanna A, et al. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery. Obes Surg. 2004; 14:840-848.
19. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-1737.
20. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med.2004;351:2683-2693.
21. Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-752.
22. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753-761.
23. Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement. Am J Clin Nutr.1992;55(suppl 2):615S-619S.
24. DeMaria EJ, Winegar DA, Pate VW, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database. Ann Surg.2010;252:559-566.
25. 2<. Surg Obes Relat Dis. 2010;6:332-338.
26. 2<: a tailored approach. Surg Obes Relat Dis.2006;2:401-404.
27. Geloneze B, Geloneze SR, Fiori C, et al. Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obes Surg. 2009;19:1077-1083.
28. Parikh M, Duncombe J, Fielding GA. Laparoscopic adjustable gastric banding for patients with body mass index of =35 kg/m2. Surg Obes Relat Dis. 2006;2:518-522.
29. O'Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med. 2006;144:625-633.
30. DePaula AL, Macedo AL, Schraibman V, et al. Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34. Surg Endosc. 2009;23:1724-1732.
31. DePaula AL, Macedo AL, Mota BR, et al. Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surg Endosc. 2009;23:1313-1320.
32. Lee WJ, Ser KH, Chong K, et al. Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. Surgery. 2010;147:664-669.
33. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases longterm mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416-423.
34. Sjöström L, Narbro K, Sjöström CD, et al; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-752.
35. Sjöström L. Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond). 2008;32(Suppl 7): S93-S97.
36. 2<: an integrative review of early studies. Obes Surg. 2010;20:776-790.
37. Kim S, Richards WO. Long-term follow-up of the metabolic profiles in obese patients with type 2 diabetes mellitus after Roux-en-Y gastric bypass. Ann Surg. 2010;251:1049-1055.
38. WJ. Bariatric surgery: risks and rewards. J Clin Endocrinol Metab.2008;93(11 Suppl 1):S89-S96.
39. Bult MJ, van Dalen T, Muller AF. Surgical treatment of obesity. Eur J Endocrinol. 2008;158:135-145.
40. Meguid MM, Glade MJ, Middleton FA. Weight regain after Roux-en-Y: a significant 20% complication related to PYY. Nutrition. 2008;24:832-842.
41. DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010;6:249-253.
42. Tiwari MM, Reynoso JF, High R, et al. Safety, efficacy, and cost-effectiveness of common laparoscopic procedures. Surg Endosc. 2011;25: 1127-1135.
43. Marsk R, Tynelius P, Rasmussen F, et al. Short-term morbidity and mortality after open versus laparoscopic gastric bypass surgery. A population- based study from Sweden. Obes Surg. 2009;19:1485-1490.